The Impact of the COVID-19 Pandemic on the Clinical Status of Patients Referred for TAVR
- PMID: 34953735
- PMCID: PMC8688159
- DOI: 10.1016/j.carrev.2021.12.017
The Impact of the COVID-19 Pandemic on the Clinical Status of Patients Referred for TAVR
Keywords: Balloon aortic valvuloplasty; COVID-19; TAVR.
Conflict of interest statement
Declaration of Competing Interest Joost Daemen received institutional grant/research support from Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Pie Medical, and ReCor medical. Nicolas Van Mieghem received research grant support from Abbott Vascular, Boston Scientific, Medtronic, Edwards Lifesciences, Daiichi Sankyo, PulseCath BV. The other authors have no conflict of interest to declare.
Figures

References
-
- Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P., 3rd, Gentile F., et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72–e227. - PubMed
-
- Leon M.B., Smith C.R., Mack M., Miller D.C., Moses J.W., Svensson L.G., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical